Simultaneous estimation of Azelnidipine and Metoprolol succinate with greenness assessment using HPLC and UV-spectrophotometric methods
Azelnidipine is a novel dihydropyridine calcium channel antagonist and Metoprolol succinate is a beta blocker, this combination was approved by CDSCO for Phase III clinical trial in April 2021. This combination is utilized to achieve a better outcome in the treatment of stage 2 hypertension. The pre...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2023-12-01
|
| Series: | Green Analytical Chemistry |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2772577423000307 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|